Long QT Syndrome

Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2).

Phase 1 Study of LQT-1213 in Healthy Adults

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function

Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults

Study of the Effect of GS-6615 in Subjects With LQT-3